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ABSTRACT 
Cobalt (Co) and chromium (Cr) ions and nanoparticles equivalent to those released through 
tribo-corrosion of prosthetic metal-on-metal (MOM) bearings and taper junctions are 
detrimental to osteoblast activity and function in-vitro when examined as individual species. 
Here we examined the effects of Co2+:Cr3+ and Co2+:Cr6+ combinations on osteoblast-like 
SaOS-2 cellular activity, alkaline phosphatase (ALP) activity and mineralization to better 
reflect clinical exposure conditions in vivo. We also assessed the effect of Co2+:Cr3+ 
combinations and Co:Cr nanoparticles on SaOS-2 cell osteogenic responses on grit-blasted, 
plasma-sprayed titanium-coated and hydroxyapatite-coated prosthesis surfaces. Cellular 
activity and ALP activity were reduced to a greater extent with combination treatments 
compared to individual ions. Co2+ and Cr3+ interacted additively and synergistically to reduce 
cellular activity and ALP activity respectively, whilst the Co2+ with Cr6+ combination was 
dominated by the effect of Cr6+ alone. Mineralization by osteoblasts was greater on 
hydroxyapatite-coated surfaces compared to grit-blasted and plasma-sprayed titanium-coated 
surfaces. Treatments with Co2+:Cr3+ ions and Co:Cr nanoparticles reduced the percentage 
mineralization on all surfaces, with hydroxyapatite-coated surfaces having the least reduction. 
In conclusion, our data suggests that previous studies investigating individual metal ions 
underestimate their potential clinical effects on osteoblast activity. Furthermore, the data 
suggests that hydroxyapatite-coated surfaces may modulate osteoblast responses to metal 
debris. This article is protected by copyright. All rights reserved 
KEYWORDS 
Hip replacement; Cobalt; Chromium; Osteoblasts; Prosthesis wear; Prosthesis surfaces 
This article is protected by copyright. All rights reserved 3 
INTRODUCTION 
The early failure of metal-on-metal prostheses, in part due to failures of osseointegration of 
cementless components, has highlighted the adverse effects of wear and corrosion mediated 
release of cobalt (Co) and chromium (Cr) on the periprosthetic environment1-3. Previous 
studies by us and others have demonstrated the detrimental effects of particulate and ionic 
forms of cobalt and chromium debris on osteoblast survival and function4-9. However, most 
studies have investigated the effects of Co and Cr ion exposure as isolated species. Whilst 
studying the effects of individual metal ions helps us discern their contribution to the 
observed detrimental effects, it does not provide us with an understanding of the effect they 
have in the clinical setting. Furthermore, the detrimental effects of CoCr alloy particles 
observed previously4; 10 are likely to be mediated, at least in part, via the simultaneous 
exposure to Co and Cr ions as a result of their intracellular oxidation11, or dissolution in 
acidic lysosomal vacuoles12. Only recently, Zijlstra et al. (2011) described an increased 
reduction in cell number with Co2+ and Cr3+ combined treatment at a ratio of 1:2 compared to 
Co2+ and Cr3+ alone, to reflect clinically observed concentrations following metal-on-metal 
total hip arthroplasty. Study of the cellular response to combined Co and Cr ions may also 
highlight any additive or synergistic interactions between ions and provide mechanistic 
insight into downstream pathways affected.  
Prosthetic surfaces are routinely modified topographically or chemically to alter their surface 
energy and wettability, making them more osseoconductive to promote osseointegration. 
Some of the most commonly used alterations to prosthesis surfaces include grit-blasting, 
plasma-sprayed titanium or hydroxyapatite coating. Previous studies with grit-blasted 
prosthesis surfaces in animal models show greater bone ongrowth observed histologically 
compared to polished surfaces, resulting in stronger mechanical fixation13-15. Studies have 
also demonstrated better bone ongrowth and fixation of hydroxyapatite-coated prosthesis 
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surfaces compared to grit-blasted surfaces16; 17. Although the effects of surface modulation on 
osseointegration have been extensively studied, the effect of metal ions and particles on the 
osteogenic response of osteoblasts on these surfaces remains unknown. 
In this study we investigated the effects of clinical relevant combinations of Co and Cr ions 
on osteoblast activity and function. We also investigated if the interactions between the metal 
ions exert an additive or synergistic effect on osteoblast activity and function. Finally, we 
characterised the effect of prosthesis surface preparations on the osteogenic response of 
osteoblasts in the presence of Co/Cr ions and nanoparticles. 
 
METHODS 
Metal ion preparation and treatments  
Cobalt (II) hexahydrate (CoCl2.6H20) and chromium (III) chloride hexahydrate (CrCl3.6H20) 
(Fluka, Gillingham, UK) served as salts for Co2+ and Cr3+ respectively. Hexavalent chromium 
(Cr6+) was purchased as chromium (VI) oxide (CrO3) from BDH Laboratory Supplies (Poole, 
UK). Working concentrations of each metal ion were prepared, as previously described18. 
The stability of these metal ions in culture media has been confirmed previously using flame-
atomic absorption spectroscopy18. Control treatment contained equivalent volume of sterile 
GLVWLOOHGZDWHUWRPDLQWDLQFRQGLWLRQVDQGUHIHUUHGWRDVȝJ/WUHDWPHQWV 
Co and Cr2O3 nanoparticles (a kind gift from Dr Ferdinand Lali, Imperial College, London, 
UK) were suspended in 100% ethanol to form a 1000X stock of the working concentration. 
Prior to treatments, the suspension was sonicated for 10 minutes to disaggregate the particles 
and diluted in osteogenic media to obtain the working concentration and observed under a 
microscope to confirm absence of aggregation. Control treatment contained equivalent 
volume of ethanol to maintain conditions. 
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Activity and function assays 
SaOS-2 cells were treated with a range of clinically relevant concentrations (0, 5, 50, 500 and 
5000µg/L) of Co2+, Cr3+ or a combination of Co2+ and Cr3+ (Co2+:Cr3+) at equal 
concentrations for 7 days19-24. Treatments with Cr6+ ranged from (0, 5, 50 and 500µg/L) 
individually, or in combination with Co2+ (Co2+:Cr6+) at equal concentrations.  
 
Prosthesis surfaces 
Sample prosthesis surfaces were supplied by JRI Orthopaedics Ltd. (Sheffield, UK) as 
clinical grade titanium (Ti6Al4V) alloy sample coupons. The dimensions of each coupon 
were 30mmx3mm (diameter x height), for culture in 6-well plates. The surfaces were 
modified using the same processes as a commercial prosthesis to achieve areal surface 
roughness (Sz) of 57µm for grit-blasted, 79µm for plasma-sprayed titanium coated surfaces 
and 66µm for hydroxyapatite-coated surfaces respectively. The coupons were gamma-
irradiated and packed in sterile conditions for subsequent cell culture.  
In this study, a combination of Co2+ and Cr3+ at 1000µg/L each was used to represent the 
concentration of metal ions in the synovial fluid19; 25. The effect of particulate wear debris 
was mimicked by treating the cells with 100 nanoparticles per cell of Co and Cr oxide (mean 
particle diameter~30nm)26; 27. 
 
Osteoblast cell culture 
Human osteosarcoma derived SaOS-2 osteoblast cells  were cultured in T75 flasks with 
'XOEHFFR¶V0(0*OXWD0$;FRQWDLQLQJ8P/SHQLFLOOLQJP/VWUHSWRP\FLQDQG
10% foetal bovine serum (FBS, Gibco®, Invitrogen, Paisley, UK) (referred to as complete 
DMEM). They were maintaiQHGDWÛ&LQDKXPLGLILHGDWPRVSKHUHRIDLUDQG&22. 
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Cellular activity 
SaOS-2 cells were seeded in a 96-well plate at a density of 5x103 cells per well in 0.2mL 
complete medium and left to adhere for the first 24 hours. The media was then replaced to 
'0(0*OXWD0$;FRQWDLQLQJ 100U/mL penicillin, 100µg/mL streptomycin and 0.5% 
)%6UHIHUUHGWRKHUHRQDVYHKLFOHPHWDOLRQWUHDWPHQWVWLOOGD\DWÛ& in a humidified 
atmosphere of 95% air and 5% CO2. The vehicle and metal ion treatments were replenished at 
day 4. Cellular activity was measured at day 7 using CellTiter 96® AQueous Non-Radioactive 
Cell Proliferation Assay according to the manufacturer's instructions (Promega, 
Southampton, UK). Cellular activity was expressed as a percentage response relative to 
vehicle. 
 
Alkaline phosphatase (ALP) activity 
SaOS-2 cells were seeded in a 96-well plate at a density of 5x103 cells per well in 0.2mL 
complete medium and left to adhere for the first 24 hours. The media was then replaced with 
vehicle ± metaOLRQWUHDWPHQWVWLOOGD\DWÛ& in a humidified atmosphere of 95% air and 
5% CO2. The vehicle and metal ion treatments were replenished at day 4. At day 7 the cells 
were washed with PBS and frozen with nuclease-free water at -Û&ALP activity was 
measured by para-nitrophenyl phosphate (pNPP, Sigma-Aldrich, Dorset, UK) hydrolysis, and 
normalised to DNA content measured by Quant-L73LFR*UHHQGV'1$$VVD\.LW
(Invitrogen, Paisley, UK). The data was expressed as a percentage response relative to 
vehicle. 
 
Mineralization Assay 
SaOS-2 cells were seeded in 48-well plates at a density of 10x103 cells per well in 0.5mL 
complete media till they reached confluence (usually day 3). The media was then replaced 
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with vehicle ± metal ion treatments supplemented with 10nM dexamethasone and 50µg/mL 
L-ascorbic acid (Sigma-Aldrich, Dorset, UK) (referred to as osteogenic media) to promote 
osteoblast differentiation. Vehicle ± metal ion treatments in osteogenic media was 
replenished every 2-3 days until two days prior to the end of experiment, when 5mM 
inorganic phosphate was added to the osteogenic media to promote mineralization. On day 7 
the cells were fixed overnight in 100% ethanol and stained with 40mM Alizarin Red S (pH 
4.2, Sigma-Aldrich, Dorset, UK). The plates were washed extensively with 95% ethanol and 
air-dried prior to scanning on a flatbed scanner. The percentage area of mineralization per 
well was quantified using ImageJ (http://imagej.nih.gov/ij/) and expressed as percentage 
response to vehicle. 
 
Mineralization on prosthesis surfaces 
Prosthesis surface mineralization was visualised by supplementing the feeding media with 
xylenol orange (Sigma-Aldrich, Dorset, UK), a fluorochrome that incorporates at sites of 
active calcification, but does not bind to hydroxyapatite coatings28-30. 
Prior to cell seeding, the prosthesis surfaces were washed with PBS and pre-wetted with 
serum-free DME0*/87$0$;IRUPLQ6D26-2 cells were seeded in 6-well plates 
containing prosthesis surfaces at a density of 15x104 cells per well in 3mL complete media 
till they reached confluence (usually day 3). Subsequently, the cells were treated with 
osteogenic media containing a combination of equivalent Co2+ and Cr3+ at 1000µg/L, or 
15x106 nanoparticles each of Co and Cr2O3. The treatments were replenished every 2-3 days 
until 4 days prior to the end of experiment, when 5mM inorganic phosphate and 20µM 
xylenol orange were supplemented in the osteogenic media. On day 21, the cells were washed 
with PBS and fixed with 10% buffered formalin for 30min. Subsequently, the surfaces 
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imaged using inverted wide-field fluorescent microscope (Leica DMI 4000B) using the N3 
filter. The images were analysed for percentage mineralization using ImageJ. 
 
Statistical analysis 
All treatment comparisons were made to the vehicle using one-ZD\$129$ZLWK'XQQHWW¶V
multiple comparisons post-test or the Kruskal-:DOOLVWHVWZLWK'XQQ¶VPXltiple comparisons 
post-test, depending on the normality of the data sets. The combinatorial effect of metal ions 
was analysed using the fractional-product method31. All analyses were conducted 2-tailed 
using a critical p-value of 0.05 using GraphPad Prism® (GraphPad Software, La Jolla, CA). 
 
RESULTS 
Effects of Co2+, Cr3+ and Cr6+ combinations on SaOS-2 cellular activity  
Following 7 day exposure with individual metal ions, SaOS-2 cell activity was unaffected by 
all metal ions up to the concentration of 5µg/L (Figure 1A-B). Cr3+ treatments decreased 
cellular activity at concentrations of 500µg/L (p<0.0001) and 5000µg/L (p<0.0001), which 
are equivalent to those observed in hip aspirates taken from patients with accelerated wear of 
an MOM bearing19; 25 (Figure 1A). Treatments with Co2+ reduced cellular activity only at the 
highest concentration of 5000µg/L (p<0.0001, Figure 1A). In comparison, Cr6+ treatments 
reduced cell activity at concentrations of 50µg/L (p<0.0001), and 500µg/L (p<0.0001, Figure 
1B). 
When SaOS-2 cells were treated with the Co2+:Cr3+ combination at 5000µg/L, an additive 
effect was observed, with a lower cell activity compared to treatment with Co2+ or Cr3+ in 
isolation (p<0.0001, Figure 1A). No further decrease in cell activity was observed for 
Co2+:Cr6+ combination treatment compared to Cr6+ alone (Figure 1B). 
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Effects of Co2+, Cr3+ and Cr6+ combinations on SaOS-2 ALP activity 
The ALP activity of SaOS-2 cells remained unaffected following 7 day treatment with 
individual metal ions up to the concentration of 50µg/L (Figure 2A-B). Co2+ and Cr3+ 
treatments caused a reduction in ALP activity at 5000µg/L (p<0.0001, Figure 2A). Cr6+ 
treatment reduced ALP activity at a lower concentration of 500µg/L (p<0.0001, Figure 2B).  
When SaOS-2 cells were treated with a combination of Co2+:Cr3+, a synergistic interaction 
was observed that further reduced the ALP activity compared to individual Co2+ and Cr3+ 
treatments at 5000µg/L (p<0.0001, Figure 2A). Co2+:Cr6+ combined treatment had a biphasic 
effect with an increase in ALP activity at 5µg/L (p<0.01) and a decrease at higher 
concentrations of 50µg/L (p<0.0001) and 500 µg/L (p<0.0001) compared to vehicle (Figure 
2B). The ALP activity with Co2+:Cr6+ combined treatment was lower compared to 50µg/L 
Co2+ (p<0.05) and, 500µg/L of Co2+ (p<0.0001) or Cr6+ (p<0.05, Figure 2B). 
 
Effects of Co2+, Cr3+ and Cr6+ combinations on SaOS-2 mineralization 
The percentage mineralization of SaOS-2 cells when grown in osteogenic media was reduced 
at concentrations of metal ions equivalent to those found in hip synovial fluid in patients with 
accelerated MOM bearing wear. Co2+ treatment at 5000µg/L reduced the percentage 
mineralization compared to vehicle (p<0.0001), whilst a reduction in mineralization was 
observed with Cr3+ treatments at 500µg/L (p<0.01) and 5000µg/L (p<0.0001, Figure 3A). 
Cr6+ treatments elicited a biphasic response with an increase in percentage mineralization at 
concentration equivalent to serum concentrations (p<0.01 at 5µg/L) and a decrease in 
mineralization at concentrations equivalent to hip synovial fluid concentrations (p<0.0001 at 
500µg/L, Figure 3B). 
Combined Co2+:Cr3+ exposure also induced a biphasic response, with an increase in the 
percentage mineralization at 500µg/L (p<0.05) and a decrease at 5000µg/L (p<0.0001) 
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compared to the vehicle (Figure 3A). The increase in percentage mineralization with 500µg/L 
of Co2+:Cr3+ was also higher compared to Co2+ and Cr3+ individually (p<0.0001, Figure 3A). 
A reduction in percentage mineralization was observed with 500µg/L (p<0.0001) Co2+:Cr6+ 
combined treatment, similar to the effect of Cr6+ alone (Figure 3B). The Co2+ and Cr6+ 
combinations did not exhibit any interactions. 
 
Effect of metal ions and nanoparticles on ALP activity of SaOS-2 cells grown on 
prosthesis surfaces 
When SaOS-2 cells were grown on hydroxyapatite-coated surfaces without metal exposure, 
the ALP activity was lower compared to that observed on grit-blasted or plasma-sprayed 
titanium surfaces (p<0.0001, Figure 4). 
In the presence of the Co2+:Cr3+ metal ion combination, the ALP activity of SaOS-2 cells 
grown on hydroxyapatite-coated surfaces remain unchanged compared to vehicle, whilst a 
reduction was observed for cells grown on grit-blasted (p<0.05) and plasma-sprayed titanium 
surfaces (p<0.0001, Figure 4). Treatments with Co:Cr nanoparticles also reduced the ALP 
activity for plasma-sprayed titanium surfaces (p<0.0001), whilst it remained unchanged for 
cells grown on hydroxyapatite-coated and grit-blasted surfaces (Figure 4). 
The ALP activity for cells cultured on hydroxyapatite coated surfaces remained lower 
compared to the grit-blasted or plasma-sprayed titanium surfaces in the presence of Co2+:Cr3+ 
(p<0.01) and Co:Cr nanoparticles (p<0.01 and p<0.05 respectively, Figure 4). There was no 
difference in ALP activity observed for cells grown on grit-blasted and plasma-sprayed 
titanium surfaces for all conditions. 
 
Effect of metal ions and nanoparticles on mineralization activity of SaOS-2 cells grown 
on prosthesis surfaces 
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When SaOS-2 cells were grown on hydroxyapatite-coated surfaces, the percentage 
mineralization was greater compared to cells grown on grit-blasted or titanium plasma-
sprayed surfaces (P<0.0001, Figure 5B). The percentage mineralization on grit-blasted 
surfaces was also higher compared to mineralization on titanium plasma-sprayed surfaces 
(p<0.05, Figure 5B). 
When SaOS-2 cells were grown on hydroxyapatite-coated surfaces in the presence of 
Co2+:Cr3+ metal ions or Co:Cr nanoparticles, the percentage mineralization was reduced by 
21% and 36%, respectively, compared to vehicle (p<0.0001, Figure 6). For grit-blasted 
surfaces, a 48% reduction in percentage mineralization was observed with Co2+:Cr3+ metal 
ion treatments, whilst treatment with Co-Cr nanoparticles reduced percentage mineralization 
by 99% (p<0.0001). When the cells were grown on plasma-sprayed titanium surfaces, a 
reduction of 86% and 88% in percentage mineralization was observed with Co2+:Cr3+ metal 
ions or Co:Cr nanoparticles treatments, respectively, compared to vehicle (p<0.0001, Figure 
6). The decrease in percentage mineralization in the presence of Co2+:Cr3+ metal ions or 
Co:Cr nanoparticles was less for hydroxyapatite-coated surfaces compared to grit-blasted or 
plasma-sprayed titanium surfaces (P<0.0001, Figure 6). 
 
DISCUSSION 
In this study we examined the effects of Co2+, Cr3+ and Cr6+ on human osteoblast-like cell 
activity, ALP activity and mineralization in vitro, at clinically relevant concentrations and 
those found in patients after MOM hip resurfacing or hip replacement19-24. A greater 
detrimental effect on cell activity and function was observed with metal ion combinations 
compared to individual metal ions. Co and Cr ions or nanoparticles also reduced the 
osteogenic response of osteoblasts grown on prosthetic surfaces, and this effect varied with 
surface preparations. 
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Our findings are consistent with the previously described detrimental effects with individual 
ions on osteoblast cellular activity in vitro6; 7. In addition, we demonstrate an additive 
detrimental effect on cell activity with chronic exposure to Co2+:Cr3+ at concentrations 
reported in the synovial fluid of some patients with a MOM bearing19; 25. The observed 
additive effect implies the existence of common downstream mechanisms for the effect of 
both Co2+ and Cr3+ on osteoblast function. Amongst other mechanisms of action, the 
participation of Co2+ and Cr3+ in Fenton-like reactions resulting in oxidative DNA damage32; 
33
, and disruption of DNA replication and repair34-36, may cause the observed additive effects. 
This is consistent with a study that describes a similar additive effect for iron (Fe2+) and Cr3+ 
combination on Fenton-like reaction mediated oxidative DNA damage37. The similarity in the 
chemical characteristics of Fe2+ and Co2+ might result in similar additive effects with Co2+ 
and Cr3+. 
In contrast to Co2+:Cr3+, the combined effect of Co2+:Cr6+ at high concentrations is dominated 
by Cr6+ toxicity with no additive or synergistic effects. Cr6+ is a known carcinogen and its 
high toxicity has been studied extensively for different cell types including osteoblasts6; 38. 
This high toxicity is likely to mask any interactions with Co2+. 
The osteogenic response of osteoblasts, assessed by ALP activity and mineralization, was 
reduced with individual Co2+, Cr3+ or Cr6+ treatment at concentrations equivalent to that 
found in the synovial fluid from some patients with MOM bearings, consistent with previous 
study findings6; 39. Simultaneous Co2+ and Cr3+ treatment resulted in synergistic interactions 
to reduce ALP activity, suggesting separate downstream actions. Alkaline phosphatase is a 
highly conserved metalloenzyme containing two Zn2+ centres which are vital to its catalytic 
activity40; 41. Previous studies have described substitution of Zn2+ by Co2+ in a variety of 
proteins including ALP, resulting in reduced ALP enzymatic activity42. In contrast, the 
effects with Cr3+ may be more indirect with induced cellular stress resulting in a reduction in 
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ALP production43. The increase in mineralization observed with 500µg/L Co2+:Cr3+ treatment 
compared to individual metal ions is an unexpected finding. Whilst the exact mechanism for 
this remains unclear, there is evidence which suggests that apoptotic or necrotic cell bodies 
are associated with nucleation of the collagen matrix around which mineralization could 
progress44-47. The previous report by Zijlstra et al. (2011) also described a greater reduction in 
cell number with combined treatments compared to individual metal ions, which might result 
in a slight increase in the nucleation of the matrix and subsequent mineralization. 
Whilst these studies suggest a detrimental effect of metal ions on prosthesis osseointegration 
and speculate on the possible mechanisms involved, they do not inform us about the role that 
prosthesis surface preparations may play in the osteogenic response of osteoblasts at the 
prosthesis-bone interface. This was assessed by measuring osteoblast ALP activity and 
mineralization on routinely used prosthesis surface preparations with and without exposure to 
Co2+:Cr3+ metal ion combination or Co:Cr nanoparticles. Our study shows that the whilst the 
ALP activity of osteoblasts grown on hydroxyapatite-coated surfaces is lower compared to 
cells grown on grit-blasted and plasma-sprayed titanium-coated surfaces, their ability to 
mineralise is much higher. This is suggestive of accelerated cellular differentiation on 
hydroxyapatite-coated surfaces, with an early peaking of ALP activity and its reduction prior 
to the increase in mineralization48-50. This is supported by the greater osteoconductivity of 
hydroxyapatite-coated surfaces reported previously51; 52. In presence of metal ions or 
nanoparticles, the ALP activity remained unchanged for cells on hydroxyapatite-coated 
surfaces, whereas a reduction was observed for both grit-blasted and plasma-sprayed 
titanium-coated surfaces compared to untreated controls. Moreover, whilst the mineralization 
on hydroxyapatite-coated surfaces was reduced with metal ions or nanoparticles, the 
reduction for both grit-blasted and plasma-sprayed titanium-coated surfaces was more severe. 
Thus, hydroxyapatite-coated surfaces may help protect the osteogenic activity of metal-
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exposed osteoblasts. These results are consistent with clinical data from the National Joint 
Registry of England and Wales, which show a 5-year revision rate of 3.9% (95%CI, 3.6-4.2) 
for the Birmingham and 5% (4.2-5.9) for Adept hip resurfacing systems that use a 
hydroxyapatite-coated acetabular prostheses, compared to 8.1% (6.7-9.8) for the Conserve 
Plus and 5.9% (4.8-7.2) for the Durom resurfacing that use a plasma-sprayed titanium 
coating1.  
This study has several limitations. The use of primary human cells to determine the effects of 
metal ions or nanoparticles would be more relevant to the clinical situation. However, a 
recent study has demonstrated similar gene expression profiles, ALP activity and 
mineralization profiles between SaOS-2 cells and primary human osteoblasts48. The use of 
Co and Cr ion combinations at the ratio of 1:1 is a representative approximation of the in vivo 
environment after hip resurfacing (but may differ in MOM hip replacement), but may vary 
clinically between patients. Finally, although commercially sourced Co and Cr nanoparticles 
are commonly used to describe tissue effects associated with MOM bearings53, the use of 
alloy wear particles generated clinically would be of more direct physiological relevance. 
In conclusion, our findings highlight species and concentration dependent interactions 
between Co and Cr ions, and show that assessment of their effects when used in combination 
is likely to be of more clinical relevance then evaluation of the isolated effects of individual 
ions. Finally, our data suggest that prosthesis surface coating may be a factor that modulates 
the effect of metal exposure on prosthesis osseointegration and survival. 
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Figure 1. Effect of metal ion combinations on osteoblast activity 
Cellular activity of SaOS-2 cells was measured using an MTS assay, after 7 day treatments 
with metal ions. The graphs are depicted with metal ion concentrations compartmentalised 
corresponding to physiological, patient serum and patient hip aspirate levels post metal-on-
metal hip replacements (MOMHR). A) The effect of Co2+:Cr3+ combinations at equal 
concentrations, and B) the effect of Co2+:Cr6+ combinations at equal concentrations. All 
values (mean ± 95%CI) are expressed relative to the vehicle (100%). n = 4-6 wells per 
experiment, 3 replicate experiments. * a p<0.05, ** b p<0.01 and *** c p<0.0001. 
 
Figure 2. Effect of metal ion combinations on osteoblast ALP activity 
ALP activity of SaOS-2 cells normalised to dsDNA after 7 day treatments with metal ions. 
The graphs are depicted with metal ion concentrations compartmentalised corresponding to 
physiological, patient serum and patient hip aspirate levels post MOMHR. A) The effect of 
Co2+:Cr3+ combinations at equal concentrations, and B) the effect of Co2+:Cr6+ combinations 
at equal concentrations. All values (mean ± 95%CI) are expressed relative to the vehicle 
(100%). n = 4-6 wells per experiment, 3 replicate experiments. * a p<0.05, ** b p<0.01 and 
*** 
c p<0.0001. 
 
Figure 3. Effect of metal ion combinations on osteoblast mineralization 
Mineralization was assessed in SaOS-2 cells cultured in osteogenic media for 7 days in the 
presence of metal ions. The graphs are depicted with metal ion concentrations 
compartmentalised corresponding to physiological, patient serum and patient hip aspirate 
levels post MOMHR. A) The effect of Co2+:Cr3+ combinations at equal concentrations, and 
B) the effect of Co2+:Cr6+ combinations at equal concentrations. All values (mean ± 95%CI) 
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are expressed relative to the vehicle (100%). n = 4-6 wells per experiment, 4 replicate 
experiments. * a p<0.05, ** b p<0.01 and *** c p<0.0001. 
 
Figure 4. ALP activity of SaOS-2 cells on prosthesis surfaces 
ALP activity of SaOS-2 cells on prosthesis surfaces with metal ions and nanoparticles 
treatments was measured after 7 days. All values represented as mean ± 95%CI from 3 repeat 
experiments with 5 replicates per experiment. * a p<0.05; b p<0.01;*** c p<0.0001. 
 
Figure 5. Effect of prosthesis surfaces on mineralization by osteoblasts 
A) Images of grit-blasted (GB), plasma-sprayed titanium coated (Ti) and plasma-sprayed 
hydroxyapatite coated (HA) surfaces used to assess osteoblast mineralization. B) Percentage 
mineralization on prosthesis surfaces measured using xylenol orange, a fluorochrome that 
incorporates into newly calcified matrix. C) Representative images of mineralization (grey) 
on prosthesis surfaces. a p<0.05 and c p<0.0001. Scale bar = 200µm. 
 
Figure 6. Effect of metal ions and nanoparticles on mineralization by SaOS-2 cells on 
prosthesis surfaces 
Mineralization by osteoblasts on prosthesis surfaces with metal ions and nanoparticle 
treatments represented as percentage response to the vehicle (y=100). All values represented 
as mean ± 95%CI from 3 repeat experiments with 3 replicates per experiment. b p<0.01; c 
p<0.0001. 
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